Navigation Links
Brennen Medical Announces Sale of XenMatrix(R)
Date:9/21/2009

ST. PAUL, Minn., Sept. 21 /PRNewswire/ -- Brennen Medical, LLC, a leader in biomaterials technology, announces the sale of its XenMatrix(R) device to Davol Inc., a subsidiary of C.R. Bard, Inc. The agreement provides Davol with the worldwide rights and related assets of the hernia products business of Brennen Medical, LLC. This acquisition includes technology for a non crosslinked xenograft device for use in soft tissue repair including hernia and abdominal wall reconstruction.

XenMatrix employs a proprietary technology that maintains an acellular structurally intact, non crosslinked porcine dermal matrix for enhanced biocompatibility in host tissue. This dermal matrix supports revascularization, remodeling and regeneration for abdominal wall and hernia repairs. Recently published data in the American Journal of Surgery from the Brigham and Women's Hospital studied the use of XenMatrix in complex abdominal wall defects and reported a 93% success rate with over 16 months follow-up.

"We are extremely pleased with the successful clinical outcomes of XenMatrix. Now with the acquisition by C.R. Bard, this product will reach a far greater number of patients worldwide, who will truly benefit from this device," said Phillip Lawin, PhD, President of Brennen Medical.

About Brennen Medical, LLC

Brennen Medical is a world leader providing biologic porcine xenograft for use in plastic reconstructive, general surgery, burn, trauma, wound, urogynecological and orthopedic soft tissue repair procedures. Demonstrated to be effective, surgeons have used Brennen's proprietary porcine technologies for over 40 years. Mediskin(R) and EZ Derm(R), XenMatrix and DermMatrix(R) provide the basis for innovation and quality to guide the Company's initiatives for a growing biosurgical market. Based in St. Paul, MN and privately held, the products are sold through a direct sales force and through partnerships with major medical device companies. In addition to porcine, Brennen also markets a line of products containing oat beta glucan, a natural complex carbohydrate successfully used to manage burn and chronic wounds.

XenMatrix and DermMatrix are trademarks and/or registered trademarks of C. R. Bard, Inc. or an affiliate.

Mediskin and EZ Derm are registered trademarks of Brennen Medical, LLC.


'/>"/>
SOURCE Brennen Medical, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
5. BioMS Medical announces its intention to renew a normal course issuer bid
6. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
7. ATS Medical Expands Open Pivot Heart Valve Offerings
8. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
9. Globus Medical Announces Record 2nd Quarter 2007 Results
10. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
11. China Medical Technologies Reports First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)... NEW YORK , June 22, 2016 /PRNewswire/ ... the growing next generation sequencing (NGS) market include ... adoption of smaller sequencers.  More accessible and affordable ... led to growing demand for consumables including sample ... The Market for Sample Preparation for Next ...
(Date:6/22/2016)... ... June 22, 2016 , ... Quantitative Radiology Solutions, the ... current participant in the Phase 1 Ventures program, is leveraging regional and federal ... Radiology Solutions helps physicians make better treatment decisions by quantifying medical imaging using ...
(Date:6/22/2016)... ... June 21, 2016 , ... New light-based technologies that facilitate a ... — promise to enable both compact, wearable devices for point-of-care diagnostics as well as ... skin. , Recent work and visionary future directions are detailed in a new open-access ...
(Date:6/22/2016)... SAN DIEGO , June 22, 2016 /PRNewswire/ ... that has developed a testing platform designed specifically ... the formation of their scientific advisory board (SAB). ... of directors, the SAB is chartered to advise ... infectious disease assay platform. Led by Dr. ...
Breaking Biology Technology:
(Date:5/9/2016)... , UAE, May 9, 2016 ... when it comes to expanding freedom for high net ... Even in today,s globally connected world, there is ... conferencing system could ever duplicate sealing your deal with ... obtaining second passports by taking advantage of citizenship via ...
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
(Date:4/13/2016)... April 13, 2016  IMPOWER physicians supporting Medicaid patients ... a new clinical standard in telehealth thanks to a ... the higi platform, IMPOWER patients can routinely track key ... body mass index, and, when they opt in, share ... visit to a local retail location at no cost. ...
Breaking Biology News(10 mins):